Table 3 Trial characteristics by funding source
From: Outcomes, Interventions and Funding in Randomised Research Published in High-Impact Journals
Any industry funding | No industry funding | P | |
|---|---|---|---|
Trials (n)a Interventions (n) | 136 149 | 220 262 | |
Intervention | |||
Drug | 115 (77%) | 114 (44%) | < 0.0001 |
Device | 13 (9%) | 4 (2%) | |
Procedure | 12 (8%) | 36 (14%) | |
Other | 9 (6%) | 108 (41%) | |
Primary outcome | |||
Single | 91 (67%) | 143 (65%) | 0.76 |
Co-primary | 26 (19%) | 49 (22%) | |
Composite | 19 (14%) | 28 (13%) | |
Surrogate | 77 (57%) | 145 (66%) | 0.20 |
Mixed | 23 (17%) | 27 (12%) | |
Hard | 36 (26%) | 48 (22%) | |
Clearly stated in abstract | 111 (82%) | 176 (80%) | 0.78 |
Result for primary outcome | |||
Benefit | 65 (44%) | 108 (41%) | 0.65 |
Neutral | 77 (52%) | 135 (52%) | |
Harm | 7 (5%) | 18 (7%) | |
Not classifiable | 0 (0%) | 1 (0%) | |